Further to our communication dated November 11, 2022, attached is a copy of the presentation to be made at Glenmark Life Sciences Limited - Investor Day 2022 which is scheduled today at 15:45 IST in Mumbai. Kindly take the same on record and acknowledge receipt.

pdf

Alivus Life Sciences Ltd.

27 Oct 2022, 11:19AM

1081.15

1.84%

Earnings Call

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdf The said transcript is also attached.

pdf

Alivus Life Sciences Ltd.

22 Oct 2022

1081.15

1.84%

Earnings Call

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2022-23 Earnings Call held on 21st October, 2022 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320221021143558.mp3 Request you to kindly take the same on record.

pdf

Alivus Life Sciences Ltd.

21 Oct 2022

1081.15

1.84%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

08 Aug 2022

1081.15

1.84%

Earnings Call

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, 5th August, 2022 for the quarter ended June 30, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q1%20FY2022-23.pdf Request you to kindly take the same on record.

pdf

Alivus Life Sciences Ltd.

05 Aug 2022

1081.15

1.84%

Earnings Call

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Audio recording of Q1 FY2022-23 Earnings Call Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q1 FY2022-23 Earnings Call held on 5th August, 2022 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320220805142632.mp3

pdf

Alivus Life Sciences Ltd.

04 Aug 2022

1081.15

1.84%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

22 Apr 2022

1081.15

1.84%

Earnings Call

Glenmark Life Sciences Ltd - 543322 - Audio Recordings Of Q4 & FY22 Earnings Call

BSE India

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q4 & FY22 Earnings Call held on April 21, 2022, on our investor website : https://www.glenmarklifesciences.com/financial-results.php under Financial Results. We request you to take note and host the same on your website.

pdf

Alivus Life Sciences Ltd.

20 Apr 2022

1081.15

1.84%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf